Charles River Laboratories International Inc (NYSE: CRL) is -22.19% lower on its value in year-to-date trading and has touched a low of $91.86 and a high of $254.15 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CRL stock was last observed hovering at around $167.95 in the last trading session, with the day’s gains setting it 9.15%.
Currently trading at $177.1, the stock is 12.32% and 18.94% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.74 million and changing 5.45% at the moment leaves the stock 8.06% off its SMA200. CRL registered -4.06% loss for a year compared to 6-month loss of 5.28%. The firm has a 50-day simple moving average (SMA 50) of $148.9018 and a 200-day simple moving average (SMA200) of $163.8963.
The stock witnessed a 19.34% gain in the last 1 month and extending the period to 3 months gives it a 62.48%, and is 13.02% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.19% over the week and 3.84% over the month.
Charles River Laboratories International Inc (CRL) has around 20100 employees, a market worth around $8.70B and $4.02B in sales. Fwd P/E is 17.14. Profit margin for the company is -0.78%. Distance from 52-week low is 92.79% and -30.32% from its 52-week high. The company has generated returns on investments over the last 12 months (-0.51%).
The EPS is expected to shrink by -6.49% this year
785.0 institutions hold shares in Charles River Laboratories International Inc (CRL), with institutional investors hold 111.58% of the company’s shares. The shares outstanding are 49.12M, and float is at 48.56M with Short Float at 4.94%. Institutions hold 110.45% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 6.1 million shares valued at $1.26 billion. The investor’s holdings represent 11.8396 of the CRL Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 5.09 million shares valued at $1.05 billion to account for 9.8699 of the shares outstanding. The other top investors are STATE STREET CORP which holds 2.09 million shares representing 4.052 and valued at over $431.52 million, while KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds 3.7031 of the shares totaling 1.91 million with a market value of $394.36 million.
Charles River Laboratories International Inc (CRL) Insider Activity
Still, SEC filings show that on May 15 ’25, MASSARO GEORGE (Director) disposed off 140 shares at an average price of $137.57 for $19260.0. The insider now directly holds 5,575 shares of Charles River Laboratories International Inc (CRL).
